Hand Sanitizer - BRICS

  • BRICS
  • In 2024, the revenue in the Hand Sanitizer market market in BRICS amounts to US$0.88bn.
  • The market is projected to witness an annual growth rate of 5.86% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, reaching US$643.50m in 2024.
  • In terms of per capita revenues, an average of US$0.27 is generated per person in BRICS in 2024.
  • Brazil, a key player in the OTC Pharmaceuticals market, has seen a surge in demand for hand sanitizers due to its large population and high rate of COVID-19 cases.

Key regions: Germany, Europe, United States, Brazil, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Hand Sanitizer market in BRICS countries is experiencing significant growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.Customer preferences for hand sanitizers have shifted in recent years, driven by increasing awareness of the importance of hand hygiene. Consumers are becoming more conscious of the need to maintain cleanliness and prevent the spread of germs, especially in crowded places such as public transportation, schools, and healthcare facilities. As a result, there is a growing demand for hand sanitizers that are convenient, effective, and gentle on the skin. Customers are also seeking products with natural ingredients and pleasant fragrances to enhance the user experience.Trends in the Hand Sanitizer market vary across the BRICS countries. In Brazil, for example, there has been a surge in demand for alcohol-based hand sanitizers, driven by the country's tropical climate and the need for effective protection against bacteria and viruses. In Russia, there is a growing trend towards eco-friendly and sustainable hand sanitizers, reflecting the increasing environmental consciousness among consumers. In India, hand sanitizers with herbal and Ayurvedic formulations are gaining popularity, as customers prefer natural and traditional remedies. China, on the other hand, is witnessing a rise in the use of hand sanitizers with moisturizing properties, as customers seek products that not only kill germs but also keep their hands soft and hydrated.Local special circumstances also contribute to the development of the Hand Sanitizer market in BRICS countries. For instance, in Brazil, the high prevalence of infectious diseases and the country's large population create a favorable environment for the growth of the hand sanitizer market. In Russia, the government's strict regulations on hygiene and sanitation in public places drive the demand for hand sanitizers. In India, the increasing urbanization and rising middle-class population are key factors that fuel the market growth. In China, the rapid urbanization, growing healthcare industry, and increasing awareness of personal hygiene contribute to the expansion of the hand sanitizer market.Underlying macroeconomic factors also play a role in the development of the Hand Sanitizer market in BRICS countries. The steady economic growth, rising disposable incomes, and changing lifestyles in these countries have led to an increase in consumer spending on personal care products, including hand sanitizers. The COVID-19 pandemic has further accelerated the market growth, as individuals and businesses prioritize hand hygiene to prevent the spread of the virus. Additionally, government initiatives and regulations to promote public health and hygiene have also contributed to the growth of the hand sanitizer market in BRICS countries.In conclusion, the Hand Sanitizer market in BRICS countries is witnessing significant growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for convenient, effective, and environmentally friendly hand sanitizers is driving the market expansion, with each country in the BRICS bloc experiencing unique trends and circumstances that shape the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)